Reducing Urban Cervical Cancer Disparities Using a Tailored MHealth Intervention to Enhance Colposcopy Attendance

What this Trial Is About

The trial investigates ways to reduce cervical cancer disparities among urban, underserved women by studying the Health Enhancement Resource System HERS intervention. This intervention aims to increase patient follow-up attendance after abnormal cervical test results, using text message-based counseling and supplemental telephone health coaching for women who miss appointments. The study uses a hybrid Type 1 effectiveness-implementation design and is conducted at multiple urban clinic sites serving predominantly low-income minority women. Participants scheduled for colposcopy after abnormal cervical tests are randomized to either Standard of Care or HERS text message interventions. Those who miss appointments in either group may receive additional interventions such as repeated text reminders or health coaching calls. The study includes sequential stages of intervention for baseline and 12-month follow-up colposcopy appointments, with different combinations of Standard of Care, HERS text messages, and health coaching offered based on attendance. During the study, all participants complete surveys at baseline and one week after each colposcopy appointment, alongside barriers assessments delivered via online surveys or text messages depending on the intervention group. Qualitative interviews are conducted with healthcare providers before and after implementation, and selected participants complete exit interviews after the 12-month appointment. The primary outcome measured is attendance at the baseline colposcopy, with secondary outcomes including attendance at the 12-month follow-up.

Reducing Urban Cervical Cancer Disparities